June 21, 2025 18:00 ET | Source: BioAge Labs, Inc. Treatment with apelin receptor agonist enhanced glycemic control and demonstrated…
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25%…
BANGALORE, India, June 20, 2025 /PRNewswire/ -- Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed-to-be-University, has once…
NEW YORK, June 17, 2025 /PRNewswire/ -- Sunrise Group has once again demonstrated its industry leadership, securing a spot among…
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical…
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever…
Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p